United States (US) Clinical Next-Generation Sequencing (NSG) Testing Market (2025-2031) | Industry, Share, Size & Revenue, Outlook, Analysis, Growth, Trends, Value, Companies, Forecast, Segmentation, Competitive Landscape

Name: United States (US) Clinical Next-Generation Sequencing (NSG) Testing Market (2025-2031) | Industry & Share
Creator: 6Wresearch
License: https://www.6wresearch.com/privacy-policy

Market Forecast By Technology (Sequencing By Synthesis, Ion Semiconductor Sequencing, Single-Molecule Real-time Sequencing, Nano Pore Sequencing, Other Sequencing Technologies), By Application (Diagnostics, Drug Discovery, Agricultural and Animal Research, Other Applications), By End User (Academic Institutes and Research Centres, Hospitals and Clinics, Pharmaceutical and Biotechnology Companies, Other End Users), By Service (Human Genome Sequencing, Single Cell Sequencing, Microbial Genome-based Sequencing, Gene Regulation Services, Animal and Plant Sequencing, Other Sequencing Services), By Workflow (Pre-Sequencing, Sequencing, Data Analysis) And Competitive Landscape

Product Code: ETC9962572	Publication Date: Sep 2024	Updated Date: Aug 2025	Product Type: Market Research Report
Publisher: 6Wresearch	Author: Sumit Sagar	No. of Pages: 75	No. of Figures: 35	No. of Tables: 20

Key Highlights of the Report:

United States (US) Clinical Next-Generation Sequencing (NSG) Testing Market Outlook
Market Size of United States (US) Clinical Next-Generation Sequencing (NSG) Testing Market, 2024
Forecast of United States (US) Clinical Next-Generation Sequencing (NSG) Testing Market, 2031
Historical Data and Forecast of United States (US) Clinical Next-Generation Sequencing (NSG) Testing Revenues & Volume for the Period 2021- 2031
United States (US) Clinical Next-Generation Sequencing (NSG) Testing Market Trend Evolution
United States (US) Clinical Next-Generation Sequencing (NSG) Testing Market Drivers and Challenges
United States (US) Clinical Next-Generation Sequencing (NSG) Testing Price Trends
United States (US) Clinical Next-Generation Sequencing (NSG) Testing Porter's Five Forces
United States (US) Clinical Next-Generation Sequencing (NSG) Testing Industry Life Cycle
Historical Data and Forecast of United States (US) Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume By Technology for the Period 2021- 2031
Historical Data and Forecast of United States (US) Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume By Sequencing By Synthesis for the Period 2021- 2031
Historical Data and Forecast of United States (US) Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume By Ion Semiconductor Sequencing for the Period 2021- 2031
Historical Data and Forecast of United States (US) Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume By Single-Molecule Real-time Sequencing for the Period 2021- 2031
Historical Data and Forecast of United States (US) Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume By Nano Pore Sequencing for the Period 2021- 2031
Historical Data and Forecast of United States (US) Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume By Other Sequencing Technologies for the Period 2021- 2031
Historical Data and Forecast of United States (US) Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume By Application for the Period 2021- 2031
Historical Data and Forecast of United States (US) Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume By Diagnostics for the Period 2021- 2031
Historical Data and Forecast of United States (US) Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume By Drug Discovery for the Period 2021- 2031
Historical Data and Forecast of United States (US) Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume By Agricultural and Animal Research for the Period 2021- 2031
Historical Data and Forecast of United States (US) Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume By Other Applications for the Period 2021- 2031
Historical Data and Forecast of United States (US) Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume By End User for the Period 2021- 2031
Historical Data and Forecast of United States (US) Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume By Academic Institutes and Research Centres for the Period 2021- 2031
Historical Data and Forecast of United States (US) Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume By Hospitals and Clinics for the Period 2021- 2031
Historical Data and Forecast of United States (US) Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume By Pharmaceutical and Biotechnology Companies for the Period 2021- 2031
Historical Data and Forecast of United States (US) Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume By Other End Users for the Period 2021- 2031
Historical Data and Forecast of United States (US) Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume By Service for the Period 2021- 2031
Historical Data and Forecast of United States (US) Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume By Human Genome Sequencing for the Period 2021- 2031
Historical Data and Forecast of United States (US) Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume By Single Cell Sequencing for the Period 2021- 2031
Historical Data and Forecast of United States (US) Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume By Microbial Genome-based Sequencing for the Period 2021- 2031
Historical Data and Forecast of United States (US) Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume By Gene Regulation Services for the Period 2021- 2031
Historical Data and Forecast of United States (US) Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume By Animal and Plant Sequencing for the Period 2021- 2031
Historical Data and Forecast of United States (US) Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume By Other Sequencing Services for the Period 2021- 2031
Historical Data and Forecast of United States (US) Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume By Workflow for the Period 2021- 2031
Historical Data and Forecast of United States (US) Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume By Pre-Sequencing for the Period 2021- 2031
Historical Data and Forecast of United States (US) Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume By Sequencing for the Period 2021- 2031
Historical Data and Forecast of United States (US) Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume By Data Analysis for the Period 2021- 2031
United States (US) Clinical Next-Generation Sequencing (NSG) Testing Import Export Trade Statistics
Market Opportunity Assessment By Technology
Market Opportunity Assessment By Application
Market Opportunity Assessment By End User
Market Opportunity Assessment By Service
Market Opportunity Assessment By Workflow
United States (US) Clinical Next-Generation Sequencing (NSG) Testing Top Companies Market Share
United States (US) Clinical Next-Generation Sequencing (NSG) Testing Competitive Benchmarking By Technical and Operational Parameters
United States (US) Clinical Next-Generation Sequencing (NSG) Testing Company Profiles
United States (US) Clinical Next-Generation Sequencing (NSG) Testing Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

How does 6Wresearch market report help businesses in making strategic decisions?

Do you also provide customisation in the market study?

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 United States (US) Clinical Next-Generation Sequencing (NSG) Testing Market Overview

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Clinical Next-Generation Sequencing (NSG) Testing Market - Industry Life Cycle

3.4 United States (US) Clinical Next-Generation Sequencing (NSG) Testing Market - Porter's Five Forces

3.5 United States (US) Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume Share, By Technology, 2021 & 2031F

3.6 United States (US) Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume Share, By Application, 2021 & 2031F

3.7 United States (US) Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume Share, By End User, 2021 & 2031F

3.8 United States (US) Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume Share, By Service, 2021 & 2031F

3.9 United States (US) Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume Share, By Workflow, 2021 & 2031F

4 United States (US) Clinical Next-Generation Sequencing (NSG) Testing Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of genetic disorders and chronic diseases driving demand for clinical NGS testing

4.2.2 Technological advancements leading to improved accuracy and efficiency in NGS testing

4.2.3 Growing adoption of personalized medicine and targeted therapies fueling the demand for NGS testing in clinical settings

4.3 Market Restraints

4.3.1 High cost associated with NGS testing limiting accessibility for some patients

4.3.2 Data security and privacy concerns hindering widespread adoption of NGS testing in clinical settings

4.3.3 Lack of standardization and regulatory challenges impacting the quality and consistency of NGS testing results

5 United States (US) Clinical Next-Generation Sequencing (NSG) Testing Market Trends

6 United States (US) Clinical Next-Generation Sequencing (NSG) Testing Market, By Types

6.1 United States (US) Clinical Next-Generation Sequencing (NSG) Testing Market, By Technology

6.1.1 Overview and Analysis

6.1.2 United States (US) Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Technology, 2021- 2031F

6.1.3 United States (US) Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Sequencing By Synthesis, 2021- 2031F

6.1.4 United States (US) Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Ion Semiconductor Sequencing, 2021- 2031F

6.1.5 United States (US) Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Single-Molecule Real-time Sequencing, 2021- 2031F

6.1.6 United States (US) Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Nano Pore Sequencing, 2021- 2031F

6.1.7 United States (US) Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Other Sequencing Technologies, 2021- 2031F

6.2 United States (US) Clinical Next-Generation Sequencing (NSG) Testing Market, By Application

6.2.1 Overview and Analysis

6.2.2 United States (US) Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Diagnostics, 2021- 2031F

6.2.3 United States (US) Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Drug Discovery, 2021- 2031F

6.2.4 United States (US) Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Agricultural and Animal Research, 2021- 2031F

6.2.5 United States (US) Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Other Applications, 2021- 2031F

6.3 United States (US) Clinical Next-Generation Sequencing (NSG) Testing Market, By End User

6.3.1 Overview and Analysis

6.3.2 United States (US) Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Academic Institutes and Research Centres, 2021- 2031F

6.3.3 United States (US) Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Hospitals and Clinics, 2021- 2031F

6.3.4 United States (US) Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Pharmaceutical and Biotechnology Companies, 2021- 2031F

6.3.5 United States (US) Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Other End Users, 2021- 2031F

6.4 United States (US) Clinical Next-Generation Sequencing (NSG) Testing Market, By Service

6.4.1 Overview and Analysis

6.4.2 United States (US) Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Human Genome Sequencing, 2021- 2031F

6.4.3 United States (US) Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Single Cell Sequencing, 2021- 2031F

6.4.4 United States (US) Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Microbial Genome-based Sequencing, 2021- 2031F

6.4.5 United States (US) Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Gene Regulation Services, 2021- 2031F

6.4.6 United States (US) Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Animal and Plant Sequencing, 2021- 2031F

6.4.7 United States (US) Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Other Sequencing Services, 2021- 2031F

6.5 United States (US) Clinical Next-Generation Sequencing (NSG) Testing Market, By Workflow

6.5.1 Overview and Analysis

6.5.2 United States (US) Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Pre-Sequencing, 2021- 2031F

6.5.3 United States (US) Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Sequencing, 2021- 2031F

6.5.4 United States (US) Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Data Analysis, 2021- 2031F

7 United States (US) Clinical Next-Generation Sequencing (NSG) Testing Market Import-Export Trade Statistics

7.1 United States (US) Clinical Next-Generation Sequencing (NSG) Testing Market Export to Major Countries

7.2 United States (US) Clinical Next-Generation Sequencing (NSG) Testing Market Imports from Major Countries

8 United States (US) Clinical Next-Generation Sequencing (NSG) Testing Market Key Performance Indicators

8.1 Turnaround time for NGS test results

8.2 Percentage of healthcare providers offering NGS testing services

8.3 Number of clinical trials utilizing NGS technology

8.4 Adoption rate of NGS testing in routine clinical practice

8.5 Patient satisfaction with NGS testing experience

9 United States (US) Clinical Next-Generation Sequencing (NSG) Testing Market - Opportunity Assessment

9.1 United States (US) Clinical Next-Generation Sequencing (NSG) Testing Market Opportunity Assessment, By Technology, 2021 & 2031F

9.2 United States (US) Clinical Next-Generation Sequencing (NSG) Testing Market Opportunity Assessment, By Application, 2021 & 2031F

9.3 United States (US) Clinical Next-Generation Sequencing (NSG) Testing Market Opportunity Assessment, By End User, 2021 & 2031F

9.4 United States (US) Clinical Next-Generation Sequencing (NSG) Testing Market Opportunity Assessment, By Service, 2021 & 2031F

9.5 United States (US) Clinical Next-Generation Sequencing (NSG) Testing Market Opportunity Assessment, By Workflow, 2021 & 2031F

10 United States (US) Clinical Next-Generation Sequencing (NSG) Testing Market - Competitive Landscape

10.1 United States (US) Clinical Next-Generation Sequencing (NSG) Testing Market Revenue Share, By Companies, 2024

10.2 United States (US) Clinical Next-Generation Sequencing (NSG) Testing Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Eritrea Clinical Next-Generation Sequencing (NSG) Testing Market

Estonia Clinical Next-Generation Sequencing (NSG) Testing Market

Ethiopia Clinical Next-Generation Sequencing (NSG) Testing Market

Fiji Clinical Next-Generation Sequencing (NSG) Testing Market

Finland Clinical Next-Generation Sequencing (NSG) Testing Market

Global Clinical Next-Generation Sequencing (NSG) Testing Market

Export potential assessment - trade Analytics for 2030

Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.

By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.

To discover high-growth global markets and optimize your business strategy:

Click Here